MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 144 filers reported holding MOMENTA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $914,000 | +57.9% | 17,411 | 0.0% | 0.01% | +66.7% |
| Q2 2020 | $579,000 | +22.2% | 17,411 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $474,000 | +51.9% | 17,411 | +10.1% | 0.00% | +50.0% |
| Q4 2019 | $312,000 | +52.2% | 15,811 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $205,000 | +4.1% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $197,000 | -14.3% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $230,000 | +31.4% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $175,000 | -57.9% | 15,811 | 0.0% | 0.00% | -66.7% |
| Q3 2018 | $416,000 | +28.8% | 15,811 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $323,000 | +12.5% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $287,000 | +29.9% | 15,811 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $221,000 | -24.6% | 15,811 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $293,000 | +9.7% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $267,000 | +26.5% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $211,000 | -11.3% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $238,000 | +28.6% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $185,000 | +8.2% | 15,811 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $171,000 | +17.1% | 15,811 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $146,000 | -33.6% | 15,811 | +6.8% | 0.00% | -50.0% |
| Q4 2015 | $220,000 | -9.5% | 14,806 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $243,000 | -28.1% | 14,806 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $338,000 | +50.2% | 14,806 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $225,000 | +26.4% | 14,806 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $178,000 | +6.0% | 14,806 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $168,000 | -6.1% | 14,806 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $179,000 | +4.1% | 14,806 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $172,000 | -34.4% | 14,806 | 0.0% | 0.00% | -50.0% |
| Q4 2013 | $262,000 | +23.0% | 14,806 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $213,000 | -4.5% | 14,806 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $223,000 | – | 14,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |